PROTEK Rigla Pharmacy Chain (Protek Group) took the first place in the rating TOP-200 Pharmacy Chains for the I half-year of 2017 prepared by the analytical group of Vademecum magazine. Compared to the similar period of 2016 the revenue of the pharmacy chain for six months increased by 30%.
'ТОP-200 Pharmacy Chains occupy 64,33% of the RF (Russian Federation) commercial market with the turnover of 345 billion Russian Rubles, including 145 billion Russian Rubles gained by TOP-10', - the analysts of the publishing office remark.
'The first place in the rating ТОP-200 is one more proof of the solid leading position of Rigla Pharmacy Chain in the retail sector of the Russian pharmaceutical market. Despite increasing consolidation, which considerably influences the balance of powers in this sector, we intend to remain number one', - Aleхander Filippov, General Director of Rigla Pharmacy Chain, said.
News listOAO Protek published this content on 04 October 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 04 October 2017 15:09:07 UTC.
Original documenthttp://www.protek-group.ru/en/news/rigla-headed-the-rating-top-200-pharmacy-chains-for-the-ist-half-year-2017/
Public permalinkhttp://www.publicnow.com/view/99C911FA6423D706B8639F3ABB9897B80D44A2CB
